{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T13:51:42Z","timestamp":1764078702020},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2008,9,11]],"date-time":"2008-09-11T00:00:00Z","timestamp":1221091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/2.0"},{"start":{"date-parts":[[2008,9,11]],"date-time":"2008-09-11T00:00:00Z","timestamp":1221091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1007\/s00277-008-0593-6","type":"journal-article","created":{"date-parts":[[2008,9,10]],"date-time":"2008-09-10T12:23:10Z","timestamp":1221049390000},"page":"319-324","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Determination of Ras-GTP and Ras-GDP in patients with acute myelogenous leukemia (AML), myeloproliferative syndrome (MPS), juvenile myelomonocytic leukemia (JMML), acute lymphocytic leukemia (ALL), and malignant lymphoma: assessment of mutational and indirect activation"],"prefix":"10.1007","volume":"88","author":[{"given":"D.","family":"Raepple","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"von Lintig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Zemojtel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Duchniewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"L\u00fcbbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. R.","family":"Boss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. S.","family":"Scheele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,9,11]]},"reference":[{"issue":"13","key":"593_CR1","doi-asserted-by":"publisher","first-page":"4008","DOI":"10.1073\/pnas.81.13.4008","volume":"81","author":"O Fasano","year":"1984","unstructured":"Fasano O, Aldrich T et al (1984) Analysis of the transforming potential of the human H-ras gene by random mutagenesis. Proc Natl Acad Sci U S A 81(13):4008\u20134012. doi:10.1073\/pnas.81.13.4008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"593_CR2","first-page":"343","volume":"111","author":"W Guo","year":"1998","unstructured":"Guo W, Tang B et al (1998) N-ras mutations in 43 Chinese cases of acute myeloid leukemia. Chin Med J (Engl) 111:343\u2013345","journal-title":"Chin Med J (Engl)"},{"key":"593_CR3","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1365-2141.1991.tb08578.x","volume":"77","author":"C Farr","year":"1991","unstructured":"Farr C, Gill R et al (1991) Analysis of ras gene mutations in childhood myeloid leukaemia. Br J Haematol 77:323\u2013327. doi:10.1111\/j.1365-2141.1991.tb08578.x","journal-title":"Br J Haematol"},{"key":"593_CR4","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/sj.leu.2403274","volume":"18","author":"LY Shih","year":"2004","unstructured":"Shih LY, Huang CF et al (2004) Acquisition of FLT3 or N-ras mutations is frequently associated with progression of myelodysplastic syndrome to acute myeloid leukemia. Leukemia 18:466\u2013475. doi:10.1038\/sj.leu.2403274","journal-title":"Leukemia"},{"key":"593_CR5","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/sj.leu.2401044","volume":"12","author":"RA Padua","year":"1998","unstructured":"Padua RA, Guinn BA et al (1998) RAS, FMS and p53 mutations and poor clinical outcome in myelodysplasias: a 10-year follow-up. Leukemia 12:887\u2013892. doi:10.1038\/sj.leu.2401044","journal-title":"Leukemia"},{"key":"593_CR6","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0092-8674(00)81872-3","volume":"88","author":"T Hunter","year":"1997","unstructured":"Hunter T (1997) Oncoprotein networks. Cell 88:333\u2013346. doi:10.1016\/S0092-8674(00)81872-3","journal-title":"Cell"},{"key":"593_CR7","first-page":"486","volume":"4","author":"K Tobal","year":"1990","unstructured":"Tobal K, Pagliuca A et al (1990) Mutation of the human FMS gene (M-CSF receptor) in myelodysplastic syndromes and acute myeloid leukemia. Leukemia 4:486\u2013489","journal-title":"Leukemia"},{"key":"593_CR8","first-page":"3074","volume":"93","author":"H Kiyoi","year":"1999","unstructured":"Kiyoi H, Naoe T et al (1999) Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia. Blood 93:3074\u20133080","journal-title":"Blood"},{"key":"593_CR9","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/(SICI)1098-2795(199701)46:1<96::AID-MRD15>3.0.CO;2-1","volume":"46","author":"LR Rohrschneider","year":"1997","unstructured":"Rohrschneider LR, Bourette RP et al (1997) Growth and differentiation signals regulated by the M-CSF receptor. Mol Reprod Dev 46:96\u2013103. doi:10.1002\/(SICI)1098-2795(199701)46:1<96::AID-MRD15>3.0.CO;2-1","journal-title":"Mol Reprod Dev"},{"key":"593_CR10","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1084\/jem.179.6.1855","volume":"179","author":"T Skorski","year":"1994","unstructured":"Skorski T, Kanakaraj P et al (1994) Negative regulation of pl20GAP GTPase promoting activity by p210bcr\/abl: implication for RAS-dependent Philadelphia chromosome positive cell growth. J Exp Med 179:1855\u20131865. doi:10.1084\/jem.179.6.1855","journal-title":"J Exp Med"},{"key":"593_CR11","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1084\/jem.181.1.307","volume":"181","author":"CL Sawyers","year":"1995","unstructured":"Sawyers CL, McLaughlin J et al (1995) Genetic requirement for Ras in the transformation of fibroblasts and hematopoietic cells by the Bcr-Abl oncogene. J Exp Med 181:307\u2013313. doi:10.1084\/jem.181.1.307","journal-title":"J Exp Med"},{"key":"593_CR12","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/0092-8674(94)90322-0","volume":"77","author":"TR Golub","year":"1994","unstructured":"Golub TR, Barker GF et al (1994) Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 77:307\u2013316. doi:10.1016\/0092-8674(94)90322-0","journal-title":"Cell"},{"key":"593_CR13","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1128\/MCB.16.8.4107","volume":"16","author":"TR Golub","year":"1996","unstructured":"Golub TR, Goga A et al (1996) Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia. Mol Cell Biol 16:4107\u20134116","journal-title":"Mol Cell Biol"},{"key":"593_CR14","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1182\/blood.V86.9.3517.bloodjournal8693517","volume":"86","author":"PG Elmberger","year":"1995","unstructured":"Elmberger PG, Lozano MD et al (1995) Transcripts of the npm-alk fusion gene in anaplastic large cell lymphoma, Hodgkin\u2019s disease, and reactive lymphoid lesions. Blood 86:3517\u20133521","journal-title":"Blood"},{"key":"593_CR15","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1365-2141.1995.tb08434.x","volume":"89","author":"W Waggott","year":"1995","unstructured":"Waggott W, Lo YM et al (1995) Detection of NPM-ALK DNA rearrangement in CD30 positive anaplastic large cell lymphoma. Br J Haematol 89:905\u2013907","journal-title":"Br J Haematol"},{"key":"593_CR16","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/0092-8674(90)90024-9","volume":"62","author":"GF Xu","year":"1990","unstructured":"Xu GF, O\u2019Connell P et al (1990) The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 62:599\u2013608. doi:10.1016\/0092-8674(90)90024-9","journal-title":"Cell"},{"key":"593_CR17","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/0092-8674(92)90407-4","volume":"69","author":"JE DeClue","year":"1992","unstructured":"DeClue JE, Papageorge AG et al (1992) Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis. Cell 69:265\u2013273. doi:10.1016\/0092-8674(92)90407-4","journal-title":"Cell"},{"key":"593_CR18","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJM199706123362404","volume":"336","author":"L Side","year":"1997","unstructured":"Side L, Taylor B et al (1997) Homozygous inactivation of the NF1 gene in bone marrow cells from children with neurofibromatosis type 1 and malignant myeloid disorders. N Engl J Med 336:1713\u20131720. doi:10.1056\/NEJM199706123362404","journal-title":"N Engl J Med"},{"key":"593_CR19","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1182\/blood.V83.8.2248.2248","volume":"83","author":"J Miyauchi","year":"1994","unstructured":"Miyauchi J, Asada M et al (1994) Mutations of the N-ras gene in juvenile chronic myelogenous leukemia. Blood 83:2248\u20132254","journal-title":"Blood"},{"key":"593_CR20","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1182\/blood.V84.10.3435.3435","volume":"84","author":"R Kalra","year":"1994","unstructured":"Kalra R, Paderanga DC et al (1994) Genetic analysis is consistent with the hypothesis that NF1 limits myeloid cell growth through p21ras. Blood 84:3435\u20133439","journal-title":"Blood"},{"key":"593_CR21","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/ng1156","volume":"34","author":"M Tartaglia","year":"2003","unstructured":"Tartaglia M, Niemeyer CM et al (2003) Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat Genet 34:148\u2013150. doi:10.1038\/ng1156","journal-title":"Nat Genet"},{"key":"593_CR22","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1182\/blood-2005-02-0531","volume":"106","author":"CP Kratz","year":"2005","unstructured":"Kratz CP, Niemeyer CM et al (2005) The mutational spectrum of PTPN11 in juvenile myelomonocytic leukemia and Noonan syndrome\/myeloproliferative disease. Blood 106:2183\u20132185. doi:10.1182\/blood-2005-02-0531","journal-title":"Blood"},{"issue":"8","key":"593_CR23","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1038\/ng2073","volume":"39","author":"B Pandit","year":"2007","unstructured":"Pandit B, Sarkozy A et al (2007) Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy. Nat Genet 39(8):1007\u20131012. doi:10.1038\/ng2073","journal-title":"Nat Genet"},{"issue":"8","key":"593_CR24","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/ng2078","volume":"39","author":"MA Razzaque","year":"2007","unstructured":"Razzaque MA, Nishizawa T et al (2007) Germline gain-of-function mutations in RAF1 cause Noonan syndrome. Nat Genet 39(8):1013\u20131017. doi:10.1038\/ng2078","journal-title":"Nat Genet"},{"key":"593_CR25","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1073\/pnas.92.4.1097","volume":"92","author":"JS Scheele","year":"1995","unstructured":"Scheele JS, Rhee JM, Boss GR (1995) Determination of absolute amounts of GDP and GTP bound to Ras in mammalian cells: Comparison of parental and ras-overproducing NIH 3T3 fibroblasts. Proc Natl Acad Sci U S A 92:1097\u20131100. doi:10.1073\/pnas.92.4.1097","journal-title":"Proc Natl Acad Sci U S A"},{"key":"593_CR26","first-page":"1804","volume":"6","author":"FC Von Lintig","year":"2000","unstructured":"Von Lintig FC, Huvar I et al (2000) Ras activation in normal white blood cells and childhood acute lymphoblastic leukemia. Clin Cancer Res 6:1804\u20131810","journal-title":"Clin Cancer Res"},{"issue":"5849","key":"593_CR27","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1126\/science.1144642","volume":"318","author":"EC Stites","year":"2007","unstructured":"Stites EC, Trampont PC et al (2007) Network analysis of oncogenic Ras activation in cancer. Science 318(5849):463\u2013467. doi:10.1126\/science.1144642","journal-title":"Science"},{"key":"593_CR28","first-page":"157","volume":"1","author":"WP Shen","year":"1987","unstructured":"Shen WP, Aldrich TH et al (1987) Expression of normal and mutant ras proteins in human acute leukemia. Oncogene 1:157\u2013165","journal-title":"Oncogene"},{"issue":"2","key":"593_CR29","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1080\/08977190500130480","volume":"23","author":"A Bernards","year":"2005","unstructured":"Bernards A, Settleman J (2005) GAPs in growth factor signalling. Growth Factors 23(2):143\u2013149. doi:10.1080\/08977190500130480","journal-title":"Growth Factors"},{"key":"593_CR30","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.4049\/jimmunol.157.7.2844","volume":"157","author":"E Gulbins","year":"1996","unstructured":"Gulbins E, Brenner B et al (1996) Activation of the Ras signaling pathway by the CD40 receptor. J Immunol 157:2844\u20132850","journal-title":"J Immunol"},{"key":"593_CR31","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/S0145-2126(98)00076-9","volume":"22","author":"B Garicochea","year":"1998","unstructured":"Garicochea B, Giorgi R, Odone VF, Dorlhiac-Llacer PE, Bendit I (1998) Mutational analysis of N-RAS and GAP-related domain of the neurofibromatosis type 1 gene in chronic myelogenous leukemia. Leuk Res 22:1003\u20131007. doi:10.1016\/S0145-2126(98)00076-9","journal-title":"Leuk Res"},{"issue":"9","key":"593_CR32","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1002\/cncr.23006","volume":"110","author":"J Cortes","year":"2007","unstructured":"Cortes J, Quint\u00e1s-Cardama A, Garcia-Manero G, O\u2019Brien S, Jones D, Faderl S et al (2007) Phase 1 study of tipifarnib in combination with imatinib for patients with chronic myelogenous leukemia in chronic phase after imatinib failure. Cancer 110(9):2000\u20132006. doi:10.1002\/cncr.23006","journal-title":"Cancer"},{"key":"593_CR33","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1182\/blood.V97.5.1399","volume":"97","author":"A Reichert","year":"2001","unstructured":"Reichert A, Heisterkamp N, Daley GQ, Groffen J (2001) Treatment of Bcr\/Abl-positive acute lymphoblastic leukemia in P190 transgenic mice with the farnesyl transferase inhibitor SCH66336. Blood 97:1399\u20131403. doi:10.1182\/blood.V97.5.1399","journal-title":"Blood"},{"key":"593_CR34","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/BF03402049","volume":"6","author":"J Halaschek-Wiener","year":"2000","unstructured":"Halaschek-Wiener J, Wacheck V, Schlagbauer-Wadl H, Wolff K, Kloog Y, Jansen B (2000) A novel Ras antagonist regulates both oncogenic Ras and the tumor suppressor p53 in colon cancer cells. Mol Med 6:693\u2013704","journal-title":"Mol Med"},{"key":"593_CR35","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1007\/PL00000675","volume":"57","author":"JS Scheele","year":"2000","unstructured":"Scheele JS, Raepple D, Luebbert M (2000) The role of Ras and other low-molecular weight guanine nucleotide (GTP)-binding proteins during hematopoietic cell differentiation. Cell Mol Life Sci 57:1950\u20131963. doi:10.1007\/PL00000675","journal-title":"Cell Mol Life Sci"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-008-0593-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-008-0593-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-008-0593-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-008-0593-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T22:21:06Z","timestamp":1684534866000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-008-0593-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9,11]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["593"],"URL":"https:\/\/doi.org\/10.1007\/s00277-008-0593-6","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9,11]]},"assertion":[{"value":"15 March 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2008","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2008","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}